PZR Antibody (Rabbit mAb) [F15F10]

CatNo: F5912

    Application: Reactivity:
    • Lane 1: 293T, Lane 2: PANC1, Lane 3: LNCAP, Lane 4: U2OS
    • Immunofluorescent analysis of HUVEC cells using F5912 (green, 1:50), Hoechst (blue) and tubulin (Red).
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000
    1:50
    1:50
    Application
    WB, IP, IF
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    30-50 kDa
    ポジティブコントロール HUVEC cells; MCF7 cells; Hep G2 cells; 293T cells; PANC-1 cells; HT-1080 cells; LNCaP cells; U-2-0S cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Add protein loading buffer to the 20 μL sample, and keep it on ice for immediate use; or determine the optimal denaturation conditions by boiling the sample at a temperature gradient (e.g., 37°C, 50°C, 70°C, 90°C, and 100°C). Cool the sample on ice and centrifuge for 5 min.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    PZR Antibody (Rabbit mAb) [F15F10] detects endogenous levels of total PZR protein.
    タンパク質の局在
    細胞内膜系
    Uniprot ID
    O95297
    Clone
    F15F10
    Synonym(s)
    Myelin protein zero-like protein 1, Protein zero-related, MPZL1, PZR
    Background
    PZR (protein zero related, MPZL1) is a type I transmembrane glycoprotein of the immunoglobulin superfamily that localizes to the plasma membrane at cell–cell contacts and migration-associated structures and functions as a signaling scaffold linking extracellular cues to Src and SHP‑2–dependent pathways. The extracellular region carries Ig‑like domains with N‑glycosylation that support recognition by the lectin concanavalin A (ConA), while the short cytoplasmic tail of the full-length isoform contains a tandem pair of immunoreceptor tyrosine‑based inhibitory motifs with tyrosines that become phosphorylated by Src family kinases including c‑Src. PZR associates constitutively with c‑Src, and ConA binding to the glycoprotein triggers robust tyrosine phosphorylation of the ITIM tyrosines, enhanced c‑Src activation, and recruitment of the SH2 domain‑containing phosphatase SHP‑2, an interaction that is blocked by Src inhibitors such as PP1 and disrupted when the PZR cytoplasmic tail is truncated. These molecular events place PZR as a major receptor for ConA‑induced signaling, where the combination of Src activation and SHP‑2 binding to phosphorylated ITIMs modulates downstream cascades that influence cytoskeletal organization, cell morphology, and cell agglutination responses. Alternative splicing of the MPZL1 transcript generates isoforms PZRa and PZRb that lack ITIM motifs, and these variants retain extracellular and transmembrane regions but differ in their capacity to couple to SHP‑2 and to transduce Src‑dependent inhibitory or modulatory signals. PZR is enriched in cardiovascular, renal, and pancreatic tissues and concentrates at interendothelial junctions, where its adhesive and signaling properties have been linked to SHP‑2‑dependent regulation of endothelial barrier function and intercellular contact organization. Increased tyrosyl phosphorylation of PZR has been detected in genetic models with activating or dysregulated SHP‑2, including Noonan‑ and LEOPARD‑syndrome–associated PTPN11 variants, and this phosphorylation correlates with enhanced SHP‑2 membrane recruitment and altered growth and differentiation signaling in affected tissues. MPZL1 amplification and PZR overexpression are reported in several tumor types, where elevated PZR signaling associates with higher c‑Src activity, increased SHP‑2 engagement, and enhanced cell migration and invasive behavior, connecting this receptor-like adaptor to metastatic programs and to disease progression in hepatocellular carcinoma and other cancers.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください